Current Recommendations from the Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria (PACCARB) (CE Session)
Description:
Date/Time: April 11, 2024 | 12:50 - 1:10 pm ET
The U.S. federal government has been addressing resistant infections for decades. In 2014, President Barak Obama signed an executive order that brought all federal efforts to combat antibiotic resistance together. The Executive Order 13676 established the National Action Plan for Combating Antibiotic-Resistant Bacteria (CARB), the Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria (PACCARB), and formally established the Federal Interagency CARB Task Force to coordinate all federal efforts. PACCARB offers guidance to the U.S. Secretary of Health and Human Services on addressing antimicrobial resistance (AMR) and operates within the Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019. PACCARB, comprised of experts from various fields, evaluates government efforts in human, animal, and environmental health.
This session will briefly summarize and review the PACCARB charter and a few of the current PACCARB reports and recommendations.
Learning Objectives:
At the end of this session, the learner should be able to: (AVOID USING DISCUSS and UNDERSTAND)
- Describe the purpose, objectives, and scope of the Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria (PACCARB);
- List PACCARB reports and describe key PACCARB recommendations.
Target Audience:
Nurses, advanced practice providers, physicians, emergency responders, pharmacists, medical technologists, respiratory therapists, physical/occupational therapists, infection prevention specialists, data/quality specialists, and more.
Jason G. Newland, MD, MEd
Pediatric Infectious Diseases
Washington University in St. Louis
Jason Newland, MD, MeD, is a Professor of Pediatrics at Washington University in St. Louis and the Director of the Antimicrobial Stewardship Program (ASP) at St. Louis Children’s Hospital. Additionally, he leads the BJC Healthcare Systems Infectious Diseases Clinical Expert Council and Antimicrobial Stewardship Collaborative. Prior to arriving at Washington University and BJC Healthcare, he was the medical director of the ASP at Children’s Mercy Hospital in Kansas City. At both Children’s Mercy Hospital and St. Louis Children’s Hospital, he has implemented effective ASPs that have observed significant improvement in antimicrobial use and improvement in patient outcomes.
Dr. Newland is a national and international leader in the field of antimicrobial stewardship. He has served on many important committees at Centers for Disease Control and Prevention (CDC) regarding antimicrobial stewardship and how to best accomplish the goals set forth in the National Action Plan for Combating Antibiotic-Resistant Bacteria. He is the Chair of the Pediatric Infectious Diseases Society’s Committee on Antimicrobial Stewardship and has led this group since its inception in 2010. His outstanding work in antimicrobial stewardship led to his invitation to the 2015 White House Forum on Antimicrobial Stewardship.
Dr. Newland’s research focuses on improving the use of antibiotics in all healthcare settings and aiding hospitals in developing and evaluating their ASPs. He has authored over 110 peer-reviewed publications in many of the leading journals on this topic. He is most recognized for his establishment of the Sharing Antimicrobial Reports for Pediatric Stewardship (SHARPS) Collaborative, a quality improvement collaborative comprised of over 60 hospitals dedicated to improving the use of antibiotics. The SHARPS Collaborative provides antimicrobial stewardship physicians and pharmacists with numerous resources to aid in improving and evaluating their program. Lastly, Dr. Newland has organized and led the only dedicated Pediatric Antimicrobial Stewardship Conference in the world. This conference began in 2010 as a one-day meeting with 30 participants. This meeting continues to grow and has become one of the premiere ASP meetings in the country.
Paul J. Plummer, DVM, PhD, DACIVIM(LAIM) DECSRHM
Executive Director
National Institute of Antimicrobial Resistance Research and Education (NIAMRRE)
Paul Plummer, DVM, PhD, DACIVIM(LAIM) DECSRHM, is the Executive Director of the National Institute of Antimicrobial Resistance Research and Education (NIAMRRE), housed at the Iowa State University Research Park. NIAMRRE’s mission is to drive collaborative and integrative research, education, and engagement to solve AMR challenges and benefit society using a One Health approach. NIAMRRE also provides local, national, and international leadership in combating antimicrobial resistance; generating evidence-based solutions for antimicrobial stewardship; contributing to improvements in the health of animals, humans, and the environment (One Health); and facilitating economically and socially sound policy development and implementation. NIAMRRE was developed in 2018 as a result of a national search process led by the Association of Public and Land-Grant Universities (APLU) and the American Association of Veterinary Medical Colleges (AAVMC) to identify a collaborative center to lead One Health efforts in AMR.
Dr. Plummer is also the Associate Dean of Research and Graduate Studies and a professor and holder of the Anderson Endowed Chair in Veterinary Science in the Departments of Veterinary Diagnostic and Production Animal Medicine and Veterinary Microbiology and Preventative Medicine at the Iowa State University College of Veterinary Medicine.